Utilization of intravenous bisphosphonates (IVBs) in patients with bone metastases (BMets) secondary to breast, lung, or prostate cancer (BC, LC, PC).
May Hagiwara
Consultant or Advisory Role - Amgen
Research Funding - Amgen
Ze Cong
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Karen Chung
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Thomas E. Delea
Consultant or Advisory Role - Amgen
Research Funding - Amgen